GlassScriptPhysician profile
Catherine B O Brien
NPI 1578513107
$583.44
in general payments reported to CMS, 2019-2025
12 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.01 · 2022: $74.25 · 2023: $109 · 2024: $187 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $161.03 | 2023-2025 | Rexulti, Jynarque, Nuedexta |
| Lundbeck LLC | $75.70 | 2022-2025 | Rexulti |
| Sun Pharmaceutical Industries INC. | $63.34 | 2021-2022 | |
| Medtronic, INC. | $61.39 | 2024 | Signia |
| Teva Pharmaceuticals USA, INC. | $45.79 | 2024 | Uzedy |
| Abbvie INC. | $45.65 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $28.80 | 2025 | Cobenfy |
| Takeda Pharmaceuticals U.S.A., INC. | $25.58 | 2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.03 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $19.99 | 2024 | |
| Acadia Pharmaceuticals INC | $18.27 | 2022 | |
| Exact Sciences Corporation | $17.87 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine O Brien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.